Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-09FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for duloxetine hydrochloride, establishing a generic version of duloxetine.
-
FDA approval · 2014-01-08FDA Approved: DULOXETINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a duloxetine generic from Zydus Lifesciences Limited, enabling marketing for the same indications …
-
FDA approval · 2013-12-17FDA Approved: DULOXETINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for a generic duloxetine product. The approval makes low-cost generic duloxetine av…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approves duloxetine hydrochloride generic by Marksans Pharma Limited under an Original ANDA (ANDA 090723).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic duloxetine under an Original Application, authorizing a generic version of the reference duloxet…
-
FDA approval · 2013-11-25FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2013-10-30FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2013-02-28FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Mylan Pharmaceuticals Inc. The approval confirms regulatory status of the generi…
-
FDA approval · 2012-12-06FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc., indicating an addition or modif…
-
FDA approval · 2012-10-30FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2011-11-08FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) from Allergan, Inc.
-
FDA approval · 2011-06-20FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2011-04-26FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) filed by Parke-Davis Div of Pfizer Inc.
-
FDA approval · 2011-04-26FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2011-04-26FDA Approved: PREGABALIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin submitted by Mylan Pharmaceuticals Inc., updating the regulatory status of the produc…
-
FDA approval · 2011-04-12FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2010-06-01FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) from Allergan, marking an update to the product's labeli…
-
FDA approval · 2010-05-17FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for Savella (milnacipran hydrochloride), updating the labeling.
-
FDA approval · 2010-01-04FDA Approved: PREGABALIN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for pregabalin from Mylan Pharmaceuticals, confirming a generic version of the drug.
-
FDA approval · 2009-04-16FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAVELLA (milnacipran hydrochloride) from Allergan, Inc., indicating approval of changes to its l…
-
FDA approval · 2009-01-14FDA Approved: SAVELLA — Original Application (Allergan, Inc.)
FDA approved SAVELLA (milnacipran hydrochloride) under an original application by Allergan, Inc. for the treatment of fibromyalgia.
-
FDA approval · 2007-06-21FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…